Veriheal

SEPTEMBER 2, 2022

estimates that 60-70% of his patients are seeking out medical cannabis for the treatment of chronic pain. In order to access medical cannabis previously, patients had to submit a request for approval by the Federal Office of Public Health, which is the government center of public health in Switzerland.

Chronic Pain 57

Chronic Pain Patients Decriminalization Cannabis 57

Veriheal

MARCH 1, 2022

The campaign manager of the ‘Yes on 109’ campaign that helped see the measure passed, Sam Chapman, told media sources, “There’s a huge breadth of expertise on this board from harm reduction experts to folks that have experience working with different populations that stand to benefit from having access to psilocybin therapy.

Therapy 98

Therapy Programs Microdosing Medicine 98

Cannabis Law Report

MAY 31, 2022

Food and Drug Administration (FDA) approved esketamine (a component of Ketamine and sold under the brand name Spravato) for treatment-resistant depression. Stay tuned… Oregon plans to accept applications for Facilitators, Laboratories, Manufacturers and Service Centers starting January 2023. On March 5, 2019, the U.S.

Clinical Trials 52

Clinical Trials Legalization Therapy Decriminalization 52

Cannabis Law Report

MAY 29, 2022

Widespread approval for psychedelic treatments remains unlikely, but the tide is slowly turning. 7] And cities around the country are beginning to decriminalize some psychedelics, with advocates for decriminalization citing the potential medical benefits. For the regulated community, this is a trend worth watching. Challenges.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Veriheal

DECEMBER 27, 2022

While it is true that psychedelics are still illegal in the United States under federal law, local and state decriminalization efforts have increased in recent years, and researchers have begun investigating their therapeutic properties. . However, it does suggest a strong association between the two.

Research and Development 95

Research and Development Therapy Consumption DEA 95

Veriheal

MARCH 29, 2023

However, a 2023 study debunks many myths about the potential dangers of legalizing cannabis. In addition, several other studies suggest that legalizing access to marijuana is actually associated with decreased: Crime Opioid overdose Mental illness rates Gone are the days when cautionary tales run rampant.

Legalization 57

Legalization Data Policy Cannabis 57

Cannabis Law Report

SEPTEMBER 22, 2022

While seemingly revolutionary, SB 1326 is contingent on an official assurance that the activity would not result in federal enforcement action against California – meaning, most likely, that this bill cannot be utilized until cannabis is federally decriminalized. SB 1186– Medicinal Cannabis Patients’ Right of Access Act. FOOTNOTES. [1]

Law 52

Law Events Packaging Pets 52

Veriheal

MARCH 4, 2022

In November 2020, Measure 110 (Drug Decriminalization and Addiction Treatment Initiative) passed by majority vote in Oregon, bringing forth a new era in combating drug addiction and prioritizing criminal justice reform in the state. Measure 110 officially decriminalized the minor personal possession of all drugs in the state of Oregon.

Decriminalization 98

Decriminalization Treatment Access Consumption 98

Veriheal

JANUARY 26, 2024

In April 2023, Delaware became the 22nd state to legalize recreational cannabis with the passing of HB 1 and HB 2. Possession of up to an ounce was decriminalized, and plans are underway to open dispensaries statewide.

Access 105

Access Legalization Marijuana Dispensary 105

Cannabis Law Report

JULY 13, 2022

A legislative panel on Tuesday listened to advocates who hope to broaden the scope of medical treatment and research assisted by psilocybin, the psychedelic active ingredient in certain mushrooms. The Democratic-led Legislature convenes its next regular session in January 2023.

Therapy 52

Therapy Legislation Access Decriminalization 52